Schonfeld Strategic Advisors’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.08M | Buy |
63,223
+42,099
| +199% | +$2.05M | 0.02% | 697 |
|
|
2025
Q1 | $455K | Sell |
21,124
-28,433
| -57% | -$612K | ﹤0.01% | 1500 |
|
|
2024
Q4 | $1.33M | Buy |
49,557
+30,057
| +154% | +$808K | 0.01% | 945 |
|
|
2024
Q3 | $210K | Buy |
19,500
+100
| +0.5% | +$1.08K | ﹤0.01% | 1653 |
|
|
2024
Q2 | $232K | Sell |
19,400
-8,200
| -30% | -$97.9K | ﹤0.01% | 1632 |
|
|
2024
Q1 | $508K | Sell |
27,600
-4,145
| -13% | -$76.3K | ﹤0.01% | 1297 |
|
|
2023
Q4 | $504K | Buy |
31,745
+1,190
| +4% | +$18.9K | ﹤0.01% | 1209 |
|
|
2023
Q3 | $576K | Sell |
30,555
-1,690
| -5% | -$31.8K | ﹤0.01% | 1048 |
|
|
2023
Q2 | $729K | Sell |
32,245
-1,075
| -3% | -$24.3K | 0.01% | 1067 |
|
|
2023
Q1 | $846K | Buy |
+33,320
| New | +$846K | 0.01% | 1001 |
|
|
2022
Q2 | – | Sell |
-545
| Closed | -$9K | – | 2493 |
|
|
2022
Q1 | $9K | Buy |
+545
| New | +$9K | ﹤0.01% | 2334 |
|